MARKET

TLRY

TLRY

TILRAY, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

17.72
-0.61
-3.30%
Opening 10:53 04/14 EDT
OPEN
18.09
PREV CLOSE
18.32
HIGH
18.13
LOW
17.46
VOLUME
5.79M
TURNOVER
--
52 WEEK HIGH
67.00
52 WEEK LOW
4.410
MARKET CAP
3.17B
P/E (TTM)
-7.3124
1D
5D
1M
3M
1Y
5Y
Cannabis Stocks Show Fresh Life Following Corrective Dip (NASDAQ: TLRY) (OTC US: CRLBF) (OTC US: MEDH) (NASDAG: SNDL) (OTC US: GRWG) (NASDAQ: APHA)
Apr 14, 2021 (OTC PR WIRE via COMTEX) -- Pot stocks have been pulling back after Aphria Inc (NASDAQ:APHA) posted less than spectacular results earlier this...
OTC · 2h ago
Tilray Inc. Cl 2 stock outperforms market on strong trading day
Shares of Tilray Inc. Cl 2 rose 6.57% to $18.32 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...
marketwatch.com · 17h ago
If You Invested $1,000 In Aphria Stock One Year Ago, Here's How Much You'd Have Now
Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return over the last 12 months is 50.3%. But there is no question some big-name stocks performed better than others alon...
Benzinga · 20h ago
Canaccord cuts Aphria to hold on industry headwinds from COVID-19
Canaccord Genuity analyst Matt Bottomley has cut shares of Aphria (APHA) from speculative buy to hold due to industry headwinds resulting from COVID-19 lockdowns.He is maintaining his price target of
Seekingalpha · 1d ago
OGI, TLRY, APHA among premarket losers
Avenue Therapeutics (ATXI) -16% after FDA continues to review NDA for IV Tramadol.Lucira Health (LHDX) -12%.OrganiGram (OGI) -12% on FQ2 results.Zomedica (ZOM) -11%.Brooklyn ImmunoTherapeutics (BTX) -10%.Fortress Biotech (FBIO) -9%.Pintec Technology (PT) -...
Seekingalpha · 1d ago
Cannabis Stocks Watchlist: Aphria Earnings Disappoints
Cannabis stocks took a hit early this week due to Aphria coming up short in its quarterly earnings release.
TheStreet.com · 1d ago
Canopy Growth vs. Tilray: How Do They Compete?
Investopedia · 1d ago
Cannabis company Aphria looks to add consumer products brands as it waits for U.S. pot legalization
Aphria CEO Irwin Simon is looking for additional opportunities to acquire brands in the consumer product space to grow the company past cannabis products.
CNBC.com · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TLRY. Analyze the recent business situations of TILRAY, INC. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 13 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TLRY stock price target is 20.55 with a high estimate of 32.00 and a low estimate of 4.770.
EPS
Institutional Holdings
Institutions: 330
Institutional Holdings: 26.73M
% Owned: 14.95%
Shares Outstanding: 178.84M
TypeInstitutionsShares
Increased
55
4.83M
New
75
7.07M
Decreased
26
2.36M
Sold Out
25
768.62K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.10%
Pharmaceuticals & Medical Research
+0.55%
Key Executives
Chief Financial Officer
Michael Kruteck
Chief Operating Officer
Jon Levin
Other
Andrew Pucher
Corporate Executive
Katy Dickson
Director
Brendan Kennedy
Independent Director
Michael Auerbach
Independent Director
Rebekah Dopp
Independent Director
Christine Clare
Independent Director
Michael ..
Independent Director
Soren Schroder
Independent Director
Christine St.Clare
No Data
About TLRY
Tilray Inc is engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Through its subsidiary, FHF Holdings Ltd (Manitoba Harvest) manufactures, markets and distributes hemp-based consumer products. The portfolio of Manitoba Harvest includes Hemp Hearts, Hemp Oil, Hemp Yeah! granola, Hemp Yeah! protein powder and Hemp Bliss milk. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe.

Webull offers kinds of Tilray Inc stock information, including NASDAQ:TLRY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLRY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TLRY stock methods without spending real money on the virtual paper trading platform.